Mink Therapeutics Inc
NASDAQ:INKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
AxoGen Inc
NASDAQ:AXGN
|
US |
|
Southwest Airlines Co
NYSE:LUV
|
US |
|
Star Entertainment Group Ltd
ASX:SGR
|
AU |
|
Funko Inc
NASDAQ:FNKO
|
US |
|
Applovin Corp
NASDAQ:APP
|
US |
|
Helical PLC
LSE:HLCL
|
UK |
|
G
|
Greencoat Renewables PLC
ISEQ:GRP
|
IE |
|
ANTA Sports Products Ltd
HKEX:2020
|
CN |
|
C
|
Charter Communications Inc
SWB:CQD
|
US |
|
Coloplast A/S
CSE:COLO B
|
DK |
|
S
|
Sigdo Koppers SA
SGO:SK
|
CL |
|
Peach Property Group AG
SIX:PEAN
|
CH |
|
Suburban Propane Partners LP
NYSE:SPH
|
US |
Wall St Price Targets
INKT Price Targets Summary
Mink Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INKT's stock price target?
Price Target
39.78
USD
According to Wall Street analysts, the average 1-year price target for
INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.